Concepedia

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis

Stephan Miehlke, Daniela E. Aust, Emese Mihály, Peter Armerding, Ole K. Bonderup, Fernando Fernández‐Bañares, Juozas Kupčinskas, Lars Kristian Munck, Kai-Uwe Rehbehn, Tanju Nacak,

Gastroenterology · 2018 · 69 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up

Filip Baert, Alain Schmit, Geert D’Haens et al. · Gastroenterology · 2002 · 275 citations · Full text

, , +8

Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial

Stephan Miehlke, Peter Heymer, B Bethke et al. · Gastroenterology · 2002 · 264 citations · Full text

, , +11

Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis

Ole K. Bonderup · Gut · 2003 · 230 citations · Full text

, , +12

Budesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study

Stephan Miehlke, Ahmed Madisch, Diana Karimi et al. · Gastroenterology · 2009 · 176 citations · Full text

, , +12

Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial

Ole K. Bonderup, Jesper Bach Hansen, P. Stubbe Teglbjærg et al. · Gut · 2008 · 168 citations

, , +12